ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,991Medicare Part D Prescriptions Filled, Including Refills

Rank: 415 out of 1677

$611K Total Retail Price of All Prescriptions

Rank: 243 out of 1677

248 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 248 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

33% of this provider’s 248 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 4,905 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 580 259 S3 1 4
CARISOPRODOL 412 82 R 2 68
ZOLPIDEM TARTRATE 300 194 3 15
SIMVASTATIN 223 155 4 1
ATORVASTATIN CALCIUM 203 129 5 13
LISINOPRIL 197 132 6 3
OMEPRAZOLE 196 113 7 6
ENDOCET 176 32 S2 8 114
LEVOTHYROXINE SODIUM 165 121 9 5
MELOXICAM 163 111 10 27
SERTRALINE HCL 157 64 11 26
DICLOFENAC SODIUM 145 93 12 95
AMLODIPINE BESYLATE 143 119 13 2
PRAVASTATIN SODIUM 140 132 14 10
NEXIUM 140 25 14 19
CRESTOR 135 73 16 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 92 17 17
METFORMIN HCL 124 43 18 7
TRAMADOL HCL 121 62 19 16
GABAPENTIN 120 43 20 11
FUROSEMIDE 120 57 20 8
FLUTICASONE PROPIONATE 112 33 22 29
AZITHROMYCIN 102 48 23 38
BISOPROLOL-HYDROCHLOROTHIAZIDE 101 87 24 107
METHADONE HCL 101 13 S2 24 168
TAMSULOSIN HCL 100 89 26 34
CEPHALEXIN 99 59 27 99
POTASSIUM CHLORIDE 92 72 28 14
LYRICA 89 12 29 81
LOSARTAN-HYDROCHLOROTHIAZIDE 85 68 30 42
PROMETHAZINE HCL 78 20 R 31 64
ALLOPURINOL 74 66 32 31
CELEBREX 72 36 33 102
PANTOPRAZOLE SODIUM 71 52 34 46
PROAIR HFA 68 28 35 50
GLIMEPIRIDE 67 42 36 33
ESTRADIOL 67 18 R 36 129
BUSPIRONE HCL 65 43 38 120
FLUCONAZOLE 63 23 39 127
OXYCODONE HCL 63 0 S2 39 91
CYMBALTA 62 23 41 58
ATENOLOL 60 51 42 21
OXYCODONE HCL-ACETAMINOPHEN 60 13 S2 42 115
HYDROCHLOROTHIAZIDE 59 40 44 9
VALACYCLOVIR 58 0 45 350
CLOPIDOGREL 58 56 45 32
METOPROLOL SUCCINATE 58 58 45 23
CARVEDILOL 52 37 48 20
OXYCONTIN 52 0 S2 48 203
TRICOR 51 39 50 100
ACTOS 51 36 50 104
LIDODERM 50 0 52 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.